• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CTA finds lesions missed by catheter angiography

Article

CT angiography can identify patients with subclinical atherosclerosis who may be inaccurately diagnosed as normal by traditional catheter angiography, according to a study at the 2004 North American Society for Cardiac Imaging meeting.

CT angiography can identify patients with subclinical atherosclerosis who may be inaccurately diagnosed as normal by traditional catheter angiography, according to a study at the 2004 North American Society for Cardiac Imaging meeting.

Jeffrey J. Fine and Dr. Richard A. Edelson of the South Carolina Heart Center in Columbia used 16-slice CTA to evaluate 40 consecutive patients within seven days after they had a normal diagnostic catheterization.

CTA identified eight patients with nonobstructive blockages in the left anterior descending artery (75% were calcific lesions and 25% soft plaque). Additionally, two of those eight had nonobstructive calcific blockages in the circumflex artery, and four had nonobstructive calcific blockages in the right coronary artery.

Although catheter angiography is the standard of reference for diagnostic angiography, it produces a 2D image with limited outer vessel visualization, preventing the identification of specific lesion types, Fine said.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.